PT141 — CAS 189691-06-3

PT141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. It acts centrally through melanocortin receptors to stimulate sexual arousal and is approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.

• Treatment of hypoactive sexual desire disorder (HSDD) in women
• Research into melanocortin receptor pharmacology
• Investigation of central pathways in sexual dysfunction
• Potential applications in male erectile dysfunction research

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support